137 related articles for article (PubMed ID: 1718139)
1. [Role of chemotherapy in squamous cell tumors of the larynx].
Merlano M; Benasso M; Cavallari M; Muttini MP
Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():129-34. PubMed ID: 1718139
[No Abstract] [Full Text] [Related]
2. [Carcinoma of the larynx: palliative radiotherapy].
Vitale V; Corvò R
Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():95-7. PubMed ID: 1718140
[No Abstract] [Full Text] [Related]
3. [Laryngeal epidermoid carcinoma in a young adult without risk factors: a case report].
M'barek B; Gargouri W; Maalej M
Tunis Med; 2005 Aug; 83(8):503-4. PubMed ID: 16238282
[TBL] [Abstract][Full Text] [Related]
4. [Role of induction chemotherapy in advanced carcinoma of the larynx].
Yu SG
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(1):43-4, 60. PubMed ID: 7688976
[TBL] [Abstract][Full Text] [Related]
5. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol.
de Andrés L; Brunet J; López-Pousa A; Burgués J; Quer M; León X; Guedea F; Vega M; Mesía R; López JJ
Laryngoscope; 1995 Aug; 105(8 Pt 1):822-6. PubMed ID: 7630294
[TBL] [Abstract][Full Text] [Related]
6. Searching for less toxic larynx preservation: a need for common definitions and metrics.
Forastiere AA; Trotti AM
J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
[No Abstract] [Full Text] [Related]
7. [Larynx preservation: nonsurgical approaches].
Bourhis J; Lefebvre JL; Temam S; Lusinchi A; Janot F; Wibault P; Pignon JP
Cancer Radiother; 2004 Nov; 8 Suppl 1():S24-8. PubMed ID: 15679243
[TBL] [Abstract][Full Text] [Related]
8. High-dose cisplatin as neoadjuvant organ-preserving chemotherapy for squamous cell carcinoma of the larynx.
Lacava JA; Ferreyra R; Leone BA; Losada C; Elem YL; Vallejo CT
Cancer J Sci Am; 1996; 2(1):46-51. PubMed ID: 9166498
[TBL] [Abstract][Full Text] [Related]
9. [Exclusive chemotherapy in T1-T3N0 cancers of the vocal cord with complete clinical response after neoadjuvant treatment with a cisplatin-fluorouracil combination].
Laccourreye O; Bassot V; Brasnu D; Jouffre V; Ménard M; Laccourreye H
Presse Med; 1995 Oct; 24(29):1337-40. PubMed ID: 7494844
[TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for laryngeal squamous cell carcinoma: current standards.
Dirix P; Lambrecht M; Nuyts S
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1461-9. PubMed ID: 20836681
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and radiation therapy for laryngeal cancer.
Hall SW; Miercort RD
Semin Speech Lang; 1995 Aug; 16(3):233-9. PubMed ID: 7584811
[No Abstract] [Full Text] [Related]
13. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
[TBL] [Abstract][Full Text] [Related]
14. [Preservation of the larynx in advanced cancer--experiences at the Oncology Department, Rambam Medical Center, Haifa].
Rosenblatt E; Siegelmann-Danieli N; Zidan J; Haim N; Kuten A
Harefuah; 2000 Oct; 139(7-8):271-4, 326. PubMed ID: 11062969
[TBL] [Abstract][Full Text] [Related]
15. Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: an alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy.
Lecanu JB; Monceaux G; Périé S; Angelard B; St Guily JL
Laryngoscope; 2000 Mar; 110(3 Pt 1):412-6. PubMed ID: 10718429
[TBL] [Abstract][Full Text] [Related]
16. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil in a case with neck recurrence of laryngeal cancer].
Nishino H; Tanaka H; Ishikawa K; Kanazawa T; Miyata M; Kitamura K
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1973-5. PubMed ID: 9797823
[TBL] [Abstract][Full Text] [Related]
17. [Laryngeal Preservation with Induction Chemotherapy. Experience of two GETTEC Centers, Between 1985 and 1995].
Janot F; Rhein B; Koka VN; Wibault P; Domenge C; Bessede JP; Marandas P; Schwaab G; Luboinski B
Ann Otolaryngol Chir Cervicofac; 2002 Feb; 119(1):12-20. PubMed ID: 11965102
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment of oesophageal adenocarcinoma.
Robb WB; Naughton P; Walsh TN
Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
[TBL] [Abstract][Full Text] [Related]
19. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
20. [In patients with cancer of the larynx, chemoradiotherapy with cisplatin is superior to neoadjuvant chemotherapy followed by radiotherapy and to exclusive radiotherapy].
Racadot S; Mazeron JJ
Bull Cancer; 2004 Mar; 91(3):211-2. PubMed ID: 15171045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
